Activation of ReqIIIβ/γ small gamma and interferon γ small gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut

Keilbaugh, S A; Shin, M E; Banchereau, R F; Mcvay, L D; Boyko, N; Artis, D; Cebra, J J; Wu, G D
May 2005
Gut;May2005, Vol. 54 Issue 5, p623
Academic Journal
Background and aims: The mechanisms by which commensal bacteria provoke intestinal inflammation in animal models of inflammatory bowel disease (IBD) remain incompletely defined, leading to increasing interest in the innate immune response of the colonic mucosa to bacterial colonisation. Methods: Using gene expression profiling of colonic RNA from C,B17.SCID germ free mice and those colonised with altered Schaedler's flora, we investigated the innate immune response to bacterial colonisation in vivo. The two most consistently induced gene groups were RegIllβ and γ as well as interferon γ (IFN-γ) response genes. Results: Using quantitative reverse transcription-polymerase chain reaction, we showed that RegIIIβ, Regillγ, and IFN-γ were constitutively expressed in the colon 0f conventionally housed SCID mice compared with either germ free SCID or conventionally housed BALB/c mice. Induction of these genes was reproduced by chronic monoassociation of germ free SCID mice with either of two separate gut commensal bacterial species-segmented filamentous bacteria and Schoedler's Escherichia coli. The cellular source for IFN-γ on monoassociation of SCID mice with Schaedler's E coli was localised to a subset of intraepithelial natural killer (IENK) cells that express asialo-GM1. In vivo IFN-γ immunoneutralisation studies failed to demonstrate any alteration in Reglllβ or γ expression. Conclusions: Thus bacterial colonisation of the colon independently activates two distinct innate immune cell types at the mucosal interface with the colonic lumen, intestinal epithelial cells, and IENK cells, a response that may be regulated by the adaptive immune system. These innate immune responses may play a role in the pathogenesis of colitis in SOD adoptive transfer models in mice and possibly in patients with IBD.


Related Articles

  • Microbes, immunoregulation, and the gut. Rook, G. A. W.; Brunet, I. R. // Gut;Mar2005, Vol. 54 Issue 3, p317 

    Two distinct, but rapidly converging, areas of research (the hygiene hypothesis and the study of probiotic/prebiotic effects) have emphasised the need to understand, and ultimately to manipulate, our physiological interactions with commensal flora, and with other transient but harmless organisms...

  • Probiotics: An Emerging Therapy. O'Sullivan, G. C.; Kelly, P.; O'Halloran, S.; Collins, C.; Collins, J. K.; Dunne, C.; Shanahan, F. // Current Pharmaceutical Design;Jan2005, Vol. 11 Issue 1, p3 

    There is considerable clinical interest in the utility of probiotic therapy - the feeding of (live) non-pathogenic bacteria, originally derived from the alimentary tract, for disease treatment or health promotion. The microflora of the gastrointestinal tract is essential for mucosal protection,...

  • World Gastroenterology Organisation Global Guideline: Inflammatory bowel disease: a global perspective - June 2009. Bernstein, Charles N.; Fried, Michael; Krabshuis, J. H.; Cohen, Henry; Eliakim, R.; Fedail, Suleiman; Gearry, Richard; Goh, K. L.; Hamid, Saheed; Khan, Aamir Ghafor; LeMair, A. W.; Malfertheiner, P.; Qin Ouyang; Rey, J.-F.; Sood, Ajit; Steinwurz, Flavio; Thomsen, Ole �.; Thomson, Alan; Watermeyer, Gillian // South African Gastroenterology Review;Aug2010, Vol. 8 Issue 2, p13 

    The article presents the global guideline for inflammatory bowel disease (IBD) from the World gastroenterology Organisation. It notes that IBD contains a group of idiopathic chronic inflammatory intestinal illnesses which has two main disease types such as Crohn's disease (CD) and ulcerative...

  • Dysbiosis in inflammatory bowel disease. Tamboli C P; Neut C; Desreumaux P; Colombel J F // Gut;Jan2004, Vol. 53 Issue 1, p1 

    Abundant data have incriminated intestinal bacteria in the initiation and amplification stages of inflammatory bowel diseases. However, the precise role of intestinal bacteria remains elusive. One theory has suggested a breakdown in the balance between putative species of "protective" versus...

  • The forgotten role of lymphangitis in Crohn's disease. Kruiningen, H J Van; Colombel, Jean-Frédéric // Gut;Jan2008, Vol. 57 Issue 1, p1 

    Research into Crohn's disease has recently been focused on the genetics of the patient, the gastrointestinal flora, the gut epithelium and mucosal immune responses. For over 60 years pathologists have reported that the fundamental alteration in Crohn's disease occurs in regional lymphatics of...

  • TOLL LIKE RECEPTORS 2 AND 4 UPREGULATED ON HUMAN LAMINA PROPRIA DENDRITIC CELLS IN INTESTINAL INFLAMMATION. Hart, A. L.; Al-Hassi, H. O.; Kamm, M. A.; Knight, S. C.; Stagg, A. J. // Gut;Apr2004 Supplement 3, Vol. 53, pA3 

    Dendritic cells (DC) are antigen presenting cells present in the intestinal tract that sample microbial products within the gut lumen and play a central role in linking innate and adaptive immunity. Recognition of microbes by DC is in part by toll like receptors (TLR). Authors assessed the...

  • Crohn's Disease and Intestinal Bacteria. Klotter, Jule // Townsend Letter;Jun2013, Issue 359, p20 

    The article reports on the connection between potentially disease-causing bacteria called pathobionts and Crohn's disease (CD). According to Dutch researcher Hermie J. M. Harmsen and colleagues, people with CD experience chronic gut inflammation because of a heightened immune response to...

  • Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Chandran, P.; Satthaporn, S.; Eremin, O.; Robins, A. // Surgeon (Edinburgh University Press);Jun2003, Vol. 1 Issue 3, p125 

    Presents a study which explored the various environmental and microbial factors that have been implicated and their relationship in the pathogenesis of inflammatory bowel disease (IBD). Commensal bacteria and the development of gut-associated lymphoid tissue; Key component of the pathogenesis...

  • Probiotic therapy in gut.  // GP: General Practitioner;10/1/2004, p19 

    This article reports the results of a study, conducted by researchers at Dundee University, which states that a pro-biotic therapy, which raises levels of "good bacteria" in the gut, may help reduce symptoms of inflammatory bowel disease. Researchers analyzed the populations of micro flora in...


Read the Article


Sign out of this library

Other Topics